1Lewin KJ,Riddel RH,Weinstein WM.Mesenchymal tumors[A].In:Lewin KJ,Riddell RH,Weinstein WM.Gastrointestinal Pathology And Its Clinical Implieations[M].1 st ed,Tokyo:Igaku-Shoin,1992,284-341
3Wang X , Mori I ,Tang W , et al. Helpful parameter for malignant potential of gastrointestinal stromal tumors( GIST ) [ J ] .Jpn J Clin Oncol, 2002, 32(9) : 347 -351.
4Miettinen M,Lasota J.Gastrointestinal stromal tumors:definition,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis[J].Virchows Arch,2001,438(1):1-12.
5Haller F,Gunawan B,von Heydebreck A,et al.Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors[J].Clin Cancer Res,2005,11(18):6589-6597.
6Eisenberg BL,Judson I.Surgery and imatinib in the management of GIST:emerging approaches to adjuvant and neoadjuvant therapy[J].Ann Surg Oncol,2004,11(5):465-475.
